MIR519d: A Non-Code RNA Molecule Regulating Cell Growth, Differentiation and Apoptosis

Target Name: MIR519D

NCBI ID: G574480

MIR519D

MIR519d: A Non-Code RNA Molecule Regulating Cell Growth, Differentiation and Apoptosis

MicroRNA 519d (miRNA 519d) is a non-coding RNA molecule that plays a critical role in various biological processes in the cell. It is a key regulator of gene expression, and is involved in the regulation of cell growth, differentiation, and apoptosis. MIR519d is also a potential drug target and biomarker, and is the focus of this article.

MIR519d is a member of the miRNA family, which are small non-coding RNAs that play a central role in post-transcriptional gene regulation. These RNAs act by binding to specific target mRNAs and regulating their stability or translation efficiency. MIR519d is a highly conserved RNA molecule, with a length of 29 amino acids and a predicted localization to the cytoplasm.

MIR519d is expressed in a variety of tissues and cells, including the brain, heart, liver, and muscle. It is highly expressed in the brain, and is also expressed in the liver, heart, and muscle. MIR519d is also expressed in various cell types, including cancer cells.

MIR519d plays a critical role in the regulation of gene expression. It is involved in the regulation of cell growth, differentiation, and apoptosis. MIR519d is a negative regulator of the Myrcobacterium marinum protein gene, and it has been shown to inhibit the expression of this gene in cancer cells.

MIR519d is also involved in the regulation of cell survival. It has been shown to play a role in the regulation of cell survival in various cell types, including cancer cells. MIR519d has been shown to interact with the Bcl-2 protein, which is a known regulator of cell survival. This interaction may contribute to the regulation of cell survival by MIR519d.

MIR519d is also a potential drug target. Its role in the regulation of cell growth, differentiation, and apoptosis makes it an attractive target for drug development. MIR519d has been shown to be a potential drug candidate in various animal models, and it is being investigated as a potential drug for the treatment of various diseases, including cancer.

In addition to its potential as a drug target, MIR519d is also a potential biomarker. Its role in the regulation of gene expression makes it an attractive candidate for use as a diagnostic or predictive marker in various diseases. MIR519d has been shown to be expressed in a variety of diseases, including cancer, and it has been used as a potential biomarker in these diseases.

MIR519d is also involved in the regulation of cellular processes that are important for human health. It has been shown to play a role in the regulation of cellular processes that are important for brain development and function, such as the regulation of neurogenesis and the regulation of synaptic plasticity.

In conclusion, MIR519d is a non-coding RNA molecule that plays a critical role in various biological processes in the cell. Its role in the regulation of gene expression, cell growth, differentiation, and apoptosis makes it an attractive target for drug development. In addition to its potential as a drug target, MIR519d is also a potential biomarker, and is being investigated as a potential diagnostic or predictive marker in various diseases. Its role in the regulation of cellular processes that are important for human health makes it an important molecule to study further.

Protein Name: MicroRNA 519d

The "MIR519D Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR519D comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets